Viewing Study NCT01422603


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2025-12-28 @ 7:33 AM
Study NCT ID: NCT01422603
Status: COMPLETED
Last Update Posted: 2018-09-07
First Post: 2011-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)
Sponsor: University Hospital Southampton NHS Foundation Trust
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: RHM CAN0638
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View